Medications

FDA approves Biogen's MS drug Plegridy

Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.

Vaccination

EU hits goal of delivering vaccines for 70% of adults

The European Union has hit its target of delivering enough coronavirus vaccine to cover 70 percent of the adult population, EU Commission President Ursula von der Leyen said Saturday.

Diseases, Conditions, Syndromes

New research identifies a threshold of immunity for COVID-19

How much immunity do we need against COVID-19? New international research led by scientists in Ireland and published in Nature Communications, has identified a "threshold of immunity" to SARS-CoV-2.

Diseases, Conditions, Syndromes

Monkeypox vaccine maker Bavarian Nordic ready to meet demand

As the lone laboratory manufacturing a licensed vaccine against monkeypox, Danish company Bavarian Nordic has seen its order book fill up as the usually rare disease spreads around the world.

page 5 from 32